Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/57071
Title: GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia.
Authors: 
Mesh: 
Issue Date: 2019
Citation: Blood Adv.2019;(3)9:1441-1449
Abstract: We report graft-versus-host disease (GVHD)-free relapse-free survival (GRFS) (a composite end point of survival without grade III-IV acute GVHD [aGVHD], systemic therapy-requiring chronic GVHD [cGVHD], or relapse) and cGVHD-free relapse-free survival (CRFS) among pediatric patients with acute leukemia (n = 1613) who underwent transplantation with 1 antigen-mismatched (7/8) bone marrow (BM; n = 172) or umbilical cord blood (UCB; n = 1441). Multivariate analysis was performed using Cox proportional hazards models. To account for multiple testing, P
PMID: 31053571
URI: https://hdl.handle.net/20.500.12530/57071
Appears in Collections:Fundaciones e Institutos de Investigación > FIB H. Infantil U. Niño Jesús > Artículos

Files in This Item:
The file with the full text of this item is not available due to copyright restrictions or because there is no digital version. Authors can contact the head of the repository of their center to incorporate the corresponding file.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.